SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019056-20-000463
Filing Date
2020-08-06
Accepted
2020-08-06 16:00:25
Documents
3
Period of Report
2020-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aptevo_8k.htm 8-K 32335
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 11385
3 GRAPHIC aptevo001.jpg GRAPHIC 3730
  Complete submission text file 0001019056-20-000463.txt   50287
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 201081417
SIC: 2834 Pharmaceutical Preparations